These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 37828249)

  • 1. Malaria & mRNA Vaccines: A Possible Salvation from One of the Most Relevant Infectious Diseases of the Global South.
    Borkens Y
    Acta Parasitol; 2023 Dec; 68(4):916-928. PubMed ID: 37828249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Malarial antigens in the era of mRNA vaccines].
    Borkens Y
    Monatsschr Kinderheilkd; 2022; 170(9):828-838. PubMed ID: 35855690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccines for preventing malaria.
    Graves P; Gelband H
    Cochrane Database Syst Rev; 2003; (1):CD000129. PubMed ID: 12535387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of vaccines against malaria; progress with contributions from the Netherlands].
    McCall MBB; Sauerwein RW
    Ned Tijdschr Geneeskd; 2020 Sep; 164():. PubMed ID: 33030326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The public health impact of malaria vaccine RTS,S in malaria endemic Africa: country-specific predictions using 18 month follow-up Phase III data and simulation models.
    Penny MA; Galactionova K; Tarantino M; Tanner M; Smith TA
    BMC Med; 2015 Jul; 13():170. PubMed ID: 26219380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Advanced Development Pathway of the RTS,S/AS01 Vaccine.
    von Seidlein L
    Methods Mol Biol; 2019; 2013():177-187. PubMed ID: 31267502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RTS,S/AS01E malaria vaccine (MoSQUIRIX*) Children living in malaria-endemic regions: little efficacy, poorly documented harms.
    Prescrire Int; 2017 Jan; 26(178):5-8. PubMed ID: 30730633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vaccination against malaria].
    Mura M
    Med Trop Sante Int; 2023 Jun; 3(2):. PubMed ID: 37525687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial.
    RTS,S Clinical Trials Partnership
    Lancet; 2015 Jul; 386(9988):31-45. PubMed ID: 25913272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The march toward malaria vaccines.
    Hoffman SL; Vekemans J; Richie TL; Duffy PE
    Vaccine; 2015 Nov; 33 Suppl 4(Suppl 4):D13-23. PubMed ID: 26324116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Delay in the Licensing of Protozoal Vaccines: A Comparative History.
    Palatnik-de-Sousa CB; Nico D
    Front Immunol; 2020; 11():204. PubMed ID: 32210953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of different components of the immune system against Plasmodium falciparum malaria: Possible contribution towards malaria vaccine development.
    Mandala WL; Harawa V; Dzinjalamala F; Tembo D
    Mol Biochem Parasitol; 2021 Nov; 246():111425. PubMed ID: 34666102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized controlled trial of RTS,S/AS02D and RTS,S/AS01E malaria candidate vaccines given according to different schedules in Ghanaian children.
    Owusu-Agyei S; Ansong D; Asante K; Kwarteng Owusu S; Owusu R; Wireko Brobby NA; Dosoo D; Osei Akoto A; Osei-Kwakye K; Adjei EA; Boahen KO; Sylverken J; Adjei G; Sambian D; Apanga S; Kayan K; Vekemans J; Ofori-Anyinam O; Leach A; Lievens M; Demoitie MA; Dubois MC; Cohen J; Ballou WR; Savarese B; Chandramohan D; Gyapong JO; Milligan P; Antwi S; Agbenyega T; Greenwood B; Evans J
    PLoS One; 2009 Oct; 4(10):e7302. PubMed ID: 19806184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malaria vaccine: the pros and cons.
    Saleh JA; Yusuph H; Zailani SB; Aji B
    Niger J Med; 2010; 19(1):8-13. PubMed ID: 20232750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The world's first malaria vaccine: Hope and challenge].
    Zhang YL; Pan WQ
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2022 Jan; 33(6):560-562. PubMed ID: 35128884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A sting in the tail-are antibodies against the C-terminus of Plasmodium falciparum circumsporozoite protein protective?
    Murdoch J; Baum J
    EMBO Mol Med; 2023 Jun; 15(6):e17556. PubMed ID: 37082835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modelling the relative cost-effectiveness of the RTS,S/AS01 malaria vaccine compared to investment in vector control or chemoprophylaxis.
    Topazian HM; Schmit N; Gerard-Ursin I; Charles GD; Thompson H; Ghani AC; Winskill P
    Vaccine; 2023 May; 41(20):3215-3223. PubMed ID: 37080831
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.